Measuring outcomes in ultra-rare bone diseases: Methodology of the palovarotene fibrodysplasia ossificans progressiva clinical development programme
Keyword(s):
2020 ◽
Vol 23
(1)
◽
pp. 1-20
◽
2006 ◽
Vol 62
(2)
◽
pp. 138-152
◽
2021 ◽
Vol 11
(1)
◽
pp. 55-69